Key PointsBioNTech and Moderna are no longer generating significant revenue from their coronavirus vaccines.
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
Key PointsBioNTech and Moderna are no longer generating significant revenue from their coronavirus vaccines....
By Dhallo News · September 4, 2026 at 3:20 AM IST
Have feedback on this article?Report error or suggestion
